{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 409092026
| IUPAC_name = (''Z'')-7-[(1''R'',2''R'',3''R'',5''S'')-3,5-dihydroxy-2-(3-oxodecyl)<br>cyclopentyl]hept-5-enoic acid
| image = Unoprostone.svg

<!--Clinical data-->
| tradename = Rescula
| Drugs.com = {{drugs.com|CONS|unoprostone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Discontinued
| legal_status = 
| routes_of_administration = Topical ([[eye drop]]s)

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 14 min
| excretion = [[Kidney|Renal]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 120373-36-6
| CAS_supplemental = {{CAS|120373-24-2}} ([[isopropyl]] ester)
| ATC_prefix = S01
| ATC_suffix = EE02
| PubChem = 5311236
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB06826
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 6X4F561V3W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08661
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201407
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4470755
<!--Chemical data-->
| C=22 | H=38 | O=5 
| molecular_weight = 382.534 g/mol
| smiles = O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CCC(=O)CCCCCCC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C22H38O5/c1-2-3-4-5-8-11-17(23)14-15-19-18(20(24)16-21(19)25)12-9-6-7-10-13-22(26)27/h6,9,18-21,24-25H,2-5,7-8,10-16H2,1H3,(H,26,27)/b9-6-/t18-,19-,20+,21-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = TVHAZVBUYQMHBC-SNHXEXRGSA-N
}}

'''Unoprostone''' ([[International Nonproprietary Name|INN]]) is a [[prostaglandin analogue]]. Its [[isopropyl]] [[ester]], '''unoprostone isopropyl''', was marketed under the trade name '''Rescula''' for the management of [[glaucoma|open-angle glaucoma]] and [[ocular hypertension]], but is now discontinued in the US.<ref>{{drugs.com|CONS|unoprostone}}</ref>

==References==
{{reflist}}


{{Antiglaucoma preparations and miotics}}
{{Prostaglandins}}
{{Prostanoidergics}}

[[Category:Prostaglandins]]


{{pharmacology-stub}}